Thank you to all who are planning to join us at Tower Grove Park for the fifth annual Sprint for Skin Cancer Event on Saturday, April 4, 2015!
If you are interested in participating in this event or making a donation, please click the following link: Registration and Sponsorship
Skin cancer is the most common cancer in the United States.
Melanoma, the deadliest skin cancer, affects one in fifty Americans. Please join our fight against these diseases.
Why We Care
Skin cancer affects one in five Americans and one in three Caucasians.
Melanoma is the deadliest form of skin cancer, one that can spread to the lymph nodes and internal organs. Once metastatic, it can be fatal.
Melanoma is the fastest growing cancer in the US and worldwide; the American Cancer Society estimates that approximately 70,230 new cases will be diagnosed in the United States alone this year.
The incidence of melanoma is increasing most rapidly in young women under the age of 40.
Melanoma is the most common form of cancer in young adults 25-29 years old, and the second most common cancer in people 15-29 years old. The average age of diagnosis is 50 years.
Every eight minutes, one American is diagnosed with melanoma. In addition, 8,800 Americans are expected to die from melanoma this year, translating to nearly one death per hour from melanoma.
Our Research
The physicians at Washington University/Barnes-Jewish Hospital take a multi-disciplinary approach to skin cancer and skin cancer research Our team includes doctors with expertise in the diagnosis and treatment of melanoma and non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) and researchers who investigate new treatments as well as the scientific, genetic and molecular basis of skin cancer development.Clinical trials are an important part of our multidisciplinary patient care, and we are able to offer our patients the newest treatment options for melanoma.You will find these listed on our website at http://siteman.wustl.edu. In addition, our physicians' and researchers' areas of investigative focus include:
Vaccine therapies for melanoma.
Research into the molecular pathways that are involved in melanoma.
Investiating novel laser imaging technologies in the diagnosis of melanoma.
Investigating the genetics of melanoma - both the genes that may be linked to familial melanoma and those that may be altered in the melanoma tumors themselves.
Contact Us: skincancer@dom.wustl.edu
